Efficacy and Safety of Early Mammalian Target of Rapamycin Inhibitors with Minimization of Calcineurin Inhibitors in Kidney Transplant Recipients

被引：0
|
作者：
Nakamura, Yuki [1 ,2 ]
Yokoyama, Takayoshi [2 ]
Kihara, Yu [2 ]
Konno, Osamu [2 ]
Iwamoto, Hitoshi [2 ]
机构：
[1] Toranomon Gen Hosp, Kidney Ctr, Dept Surg, Minato Ku, Tokyo, Japan
[2] Tokyo Med Univ, Hachioji Med Ctr, Kidney Dis Ctr, Dept Kidney Transplantat Surg, Hachioji, Tokyo, Japan
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
10.1097/01.tp.0000543262.84216.b7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.007
引用
收藏
页码：S464 / S464
页数：1
相关论文
共 50 条
  • [1] Conversion of Calcineurin Inhibitors With Mammalian Target of Rapamycin Inhibitors After Kidney Transplant
    Nikoueinejad, Hassan
    Soleimani, Alireza
    Mirshafiey, Abbas
    Amirzargar, Aliakbar
    Sarrafnejad, Abdolfattah
    Kamkar, Ideh
    Einollahi, Behzad
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (01) : 12 - 16
  • [2] Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients
    Hasbal, Nuri Baris
    Turgut, Didem
    Oguz, Ebru Gok
    Ulu, Sena
    Gungor, Ozkan
    ANNALS OF TRANSPLANTATION, 2021, 26
  • [3] The impact of calcineurin inhibitors and mammalian target of rapamycin inhibitors on anxiety and depression scores in kidney transplant patients
    Gok Oguz, Ebru
    Ulusal Okyay, Gulay
    Akoglu, Hadim
    Karaveli Gursoy, Guner
    Ercan, Zafer
    Merhametsiz, Ozgur
    Canbakan, Basol
    Ayli, Mehmet Deniz
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (05) : 1341 - 1347
  • [4] Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients
    Badve, Sunil V.
    Pascoe, Elaine M.
    Burke, Michael
    Clayton, Philip A.
    Campbell, Scott B.
    Hawley, Carmel M.
    Lim, Wai H.
    McDonald, Stephen P.
    Wong, Germaine
    Johnson, David W.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (10): : 1845 - 1855
  • [5] MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AND CLINICAL OUTCOMES IN ADULT KIDNEY TRANSPLANT RECIPIENTS
    Badve, S. V.
    Burke, M.
    Clayton, P.
    Campbell, S. B.
    Hawley, C. M.
    Lim, W. H.
    Mcdonald, S. P.
    Pascoe, E.
    Wong, G.
    Johnson, D. W.
    NEPHROLOGY, 2015, 20 : 48 - 48
  • [6] Cardiovascular Risk in Kidney Transplant Recipients Receiving Mammalian Target of Rapamycin Inhibitors
    Watorek, E.
    Szymczak, M.
    Boratynska, M.
    Patrzalek, D.
    Klinger, M.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) : 2967 - 2969
  • [7] Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
    Leal, Rita
    Tsapepas, Demetra
    Crew, Russell J.
    Dube, Geoffrey K.
    Ratner, Lloyd
    Batal, Ibrahim
    KIDNEY INTERNATIONAL REPORTS, 2018, 3 (02): : 281 - 290
  • [8] The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant
    Boswell, A
    Evans, L
    Rigg, K
    Shehata, M
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) : 884 - 885
  • [9] A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients
    Lim, W. H.
    Eris, J.
    Kanellis, J.
    Pussell, B.
    Wiid, Z.
    Witcombe, D.
    Russ, G. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (09) : 2106 - 2119
  • [10] THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Asanga, Abeyaratne
    Michael, Collins
    Kym, Bannister
    Graeme, Russ
    IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (08): : A1 - A1
12345